Tag Archives: medical

Medical Billing Business Plan


Medical Billing Business Plan


Medical billing services exist today to help with the management of medical practices. These services relieve medical professionals of tedious detail work, but rarely do they offer a means to substantially maximize the practice’s bottom line. Physicians1st Billing and Claims is a service that will allow office staff to focus on more important tasks and maximize the return from their insurance carriers.

According to national statistics, only 70% of insurance claims that were initially submitted on paper are ever paid. The percentage of claims that are paid to insurance carriers can be increased by using electronic submissions, such as Physicians 1st Billing and Claims.

Additional statistics suggest that the current cost for a medical clinic to process insurance claims on patients is between $8.00-$10.00. Physicians 1st Billing and Claims can reduce these costs by 50 percent or more.

Statistics show that paper claims turnaround times can take up to 30-60 days, or even 90 days, which creates serious outstanding receivables. Physicians 1st Billing and Claims is able to have money in the doctor’s hands within 14-18 working days by electronically submitting claims. This will reduce outstanding receivables in proportion and significantly improve cash flow.

Statistics also indicate a 30% rate of rejection or suspension for paper claims. This does not necessarily mean that claims are never paid. It does however mean that medical staff have to deal with insurance companies over payment. With the extensive editing performed on electronic claims prior to their transmission to carriers, this percentage is reduced to 2-3 percent. Claims are submitted accurately at 98 percent.

Many years ago, doctors graduated from medical school believing that they would run a “practice.” Many simple administrative procedures were neglected, such as:

  • Staying current with regulations and insurance specifications so that claims are paid promptly.
  • Concentrate on collecting receivables or co-payments.
  • Ensuring that fees were kept at the maximum allowable insurance carriers were paying, or
  • In order to ensure that claims weren’t rejected or suspended, the procedure codes were always current.

In many offices, the number of outstanding receivables grew dramatically and annual bad debt write-offs became a common practice. But adequate profit margins allowed medical practices to ignore sound business procedures. In the past, medical practice complacency about industry changes is now a thing of the passé. Four years ago, physicians began to pay attention to public opinion on health care reform. Physicians are seeing their profit margins shrink due to the infiltration of managed care companies into the industry. They now realize the importance of adopting more efficient business strategies in order for them to survive into the 21stcentury. Physicians 1st Billing and Claims is prepared to assist local health care providers move through the last of the 20th century and into the 21st century with sound practices that will guarantee business success and, in turn, guarantee quality health care for our families and our country.

Physicians 1st Billing and Claims provides over $9,000 for this business. We need to borrow an additional $5,000. This business plan is very important. This section explains how to use these funds.

1.1 Objectives

  1. You can open one account before the end of month 2.
  2. 1500 claims per month, 15
  3. To become recognized as a local industry expert in the field of medical reimbursement.
  4. You may also add the following services to our initial offer of electronic claims submission:

    • Code optimization
    • Analysis of managed care contracts
    • Full practice management.
    • Customized reporting
    • Medical transcription.
    • Analysis of fees
    • Medicare financial impact analysis.

1.2 Mission

Physicians 1st Billing and Claims, a medical reimbursement consulting company, helps medical practices to become more efficient and to save money by allowing them outsource their medical billing and insurance processing to an expert reimbursement service. We plan to provide a one-stop solution for all administrative needs of medical practice administration by 1998. We plan to make enough profit by 1998 to repay our business start-up loan, and to finance our continued growth and development through our quality service.

1.3 Keys To Success

The Federal Government has been encouraging electronic submissions of insurance claims since 1985. Electronic submission can result in millions of dollars being saved annually, according to statistics. Presently, 95 percent of all pharmaceutical claims and 70 percent of hospital claims are submitted electronically. The percentage of electronic submissions for physician and dentist claims is far lower than that for physicians and dentists, which are only 25-30%.

The Federal Government is not happy that this situation exists so Congress in 1990 mandated that doctors file claims on behalf all Medicare patients. Many doctors weren’t prepared for the avalanche of paperwork. Doctors still manage to get out from under the paper eight years later. In 1996, congress heard the calls for electronic submission of all Medicare claim. No mandate was passed but the paperwork continues to mount up and as baby boomers near retirement age the paper problem will only get worse and those echoes will turn into screams. The United States will issue more than 1 trillion dollars in medical bills this year. This is 9 billion medical claims. Medical practices will be forced to meet the mandates, and growing mountains of paper and most are not currently equipped to handle the transition. The best solution is to hire experts to help you save money, get your claims processed quickly, and make sure that the claims are handled accurately. It is rare for businesses to say that the Federal Government is supporting them every step of the way.

A second key to our success will be flexibility. Physicians 1st Billing and Claims knows that each medical practice has its own unique characteristics. Even practices of the same specialty will have different staff and offer different services. Physicians 1st Billing and Claims assess the needs of each practice and will offer solutions to make the practice more efficient. One person may need all services while another may prefer a specific set of services. Each office’s needs will be considered when billing is done.

Diversified services are the third key. Physicians 1st Billing and Claims gives you a single-stop shopping experience when it comes to medical administrative services.

Medical Equipment Developer Business Plan


Medical Equipment Developer Business Plan


Medquip, Inc., an American medical device company, plans to patent, design, and market medical devices that are related to niche markets for endoscopic surgery. With the help of surgeons and physicians in gastroenterology, three devices were already designed. Seven patents have already been filed. The company plans to achieve $16million in sales by the end of year 3. The company plans to generate $50 million in revenue for the fifth year. The company has already used a top patent law office to file patent applications for its three first market entries.

The market segments are well defined and are all subject to high growth trends. One market is projected at $160 million within the next three year. This market is endoscopic variceal (ligation) Medquip was one of the original founders and helped to design the market leader. The product has since been greatly improved by Medquip. Another market addresses a clearly defined and unmet need in endoscopic surgical: clearing the fundal pools and tissue during surgery. A new and innovative design has been created to answer the needs of surgeons.

This market should begin at $20 million but could expand to several hundred million as soon as approvals are obtained for many varied surgical procedures. Medquip intends licensing this technology to a bigger company. The company becomes mature by year three. The company may be profitable in year three if a license agreement can be signed.

Mission

Medquip, Inc.’s mission is to develop, market, and patent new technologies in the field of medical devices. The technologies will fill market niches that each account for a minimum of $20 million dollars in potential sales. Each technology will either be an improvement on an existing technology, device, or design a new device to meet a clearly defined medical need. Each product will be priced to appeal primarily to managed-care customers that focus on the lowest possible cost of treatment.

Keys to Success

The keys to success for Medquip, Inc. are as follows:

  1. Initial capitalization obtained.
  2. All filed patent applications
  3. Ability to generate revenue early from European markets that are not regulated.
  4. Licensing of at least one technology.
  5. To fully finance product development and prototyping, you can get low-interest loans and/or grants.
  6. Recruiting top-notch leaders before second round financing.
  7. Successful 510k approval from FDA to market Visi-Band in the U.S.
  8. Implementation of a successful sales and marketing strategy to the U.S. managed-care market in order to achieve minimum 10% market share for $16 million revenue.
  9. Increased product development and continued market share gains to produce a $50 million revenue company by year five.

Objectives

Medquip, Inc. has the following principal goals:

  1. To have a 10% market share in the endoscopic variceal market by year three.
  2. To make $16million in revenue by year 3.
  3. In the first six months, to raise $1 million in private seed capital.
  4. To obtain low interest loans from Puerto Rico and grants of $1.2 million each year.
  5. To license its technology for the obliteration/suction/irrigation market for $1 million dollars in year one.


Medical Internet Marketing Business Plan


Medical Internet Marketing Business Plan


DocBuzz, Inc., a medical marketing firm, specializes in medical device detailing, pharmaceutical, and biotechnical. DocBuzz, Inc., a company that is exclusively for doctors and the medical community, is the only one of its kind. DocBuzz, Inc. was founded and managed by practicing physicians.

With revenues in excess of $96.3 million annually, the pharmaceutical industry is one of most profitable. The problem facing the pharmaceutical sector is simply time. Time to research and develop, time for branding and marketing, time for sales and time to gain the trust of the medical profession. In this industry, we can equate time with money.

There are also two industries that have similar problems with their products. These are biotech companies and medical device firms. These companies have to compete with other industries for their revenues, even though the revenue is not as high as the pharmaceutical industry.

DocBuzz, Inc., developed a method that allows these industries to benefit prelaunch marketing, product brand, and postlaunch sales support. All this was done with the direct involvement of physicians. DocBuzz, Inc., gives the client companies the opportunity to market directly to the decision makers, establishing immediate credibility through our extensive network of physicians and other medical professionals. Our e­detailing is the most cost-effective option of all services. Live conferences are available, 24 hours per day, seven days a săptămână. This service provides access to an array of current information, including new biotech developments, pharmaceutical products and medical devices.

DocBuzz, Inc., will serve the marketing needs of the medical device, biotech, pharmaceutical and biotech industries. Our physicians have direct access to us and we can also provide our services. We can deliver these companies’ message directly to the decision makers for 75% of what these industries are currently budgeting. In addition, DocBuzz, Inc., by virtue of its unique incentive program will allow additional revenue to participating physicians and other medical practitioners.

DocBuzz’s winning strategy is to give the best and most accurate information to the medical professionals. The industry can also use DocBuzz to promote, market and advertise their products through highly respected doctors. Individual medical professionals benefit by being able to access the most recent industry information via the Internet. Additionally, at the end the e-detailing will allow them to request samples, additional information about the product, or to have a representative from a pharmaceutical company visit. Professionals on our medical panel can earn points by participating in our e-detailing and/or by referral of others who join our program.

1.1 Keys to Success

DocBuzz, Inc., identified four key strategies that are critical to our success.

  1. To increase market acceptance of a product, and its prescribing patterns, the Internet technology was developed to improve the access of the prescribing physician to the pharmaceuticals.
  2. DocBuzz, Inc. uses a grass-root approach to recruit and keep participating prescribing physicians through a value referral program (VIRP). DocBuzz, Inc., as a physician owned and operated company, understands physician’s needs and offers, in addition to our unique VIRP system, other value added programs such as CME, physician cyber meeting places and other extensive point redemption options.
  3. DocBuzz, Inc. can provide evidence-based analysis for the pharmaceutical industry in order to justify the pharmaceutical investment in e-detailing.
  4. DocBuzz, Inc., expects to experience rapid, but controlled, growth in order for us to keep our quality service.

1.2 Mission

DocBuzz, Inc., is a reliable, high-quality option to in-house resources. DocBuzz, Inc., helps to increase the return on marketing and sales investment by expediting the physician learning curve regarding prelaunch, new, existing and postlaunch products. It also provides access via the Internet to educational details and market research. DocBuzz, Inc., also benefits small, innovative biotechnology and pharmaceutical businesses that do not have a strong North American sales force.

1.3 Objectives

  • To establish ourselves as a premier pharmaceutical e-detailing company, targeting medical professionals–i.e. doctors, nurse practitioners, physician assistants and dentists.
  • We will provide value added services like CME and current medical information updates.
  • To hire both current and unidentified staff to help us implement our business plan.
  • To sign up 5% of the more than 650K prescribing medical professionals by year three, and provide 300K pharmaceutical detailing per year, by year three.
  • To reach a breakeven point in year two of $35,936
  • Sports Medical Equipment Business Plan


    Sports Medical Equipment Business Plan


    Professional Athletic Equipment, Inc. is going to manufacture and market a protective product for young athletes. The brand name and identity for the product will be Body Armor. The product is designed to protect the abdomen, chest, and side from injury caused by blunt trauma. This device can also prevent sudden death due to commotio cordis (heart attack caused by external trauma). This injury is most common in baseball, but it can also happen in other sports. The United States has filed a patent application for the device.

    This business plan is part our regular business planning process. This plan gets a semi-annual update.

    In the coming year, we plan to manufacture and market our first product. So far, there have not been any sales.

    We expect to sell 750 units per months on average during year one of our marketing campaigns. This will translate into a sales volume of $242 550 per year. Management projects that the company will achieve sales of more than $4 million and profitability by year three. After taxes, year three profits are $593570.

    Our keys to success and critical factors for the next year are, in order of importance:

    • Initial product production on first three sizes.
    • For product acceptance testing, you can do basic research and test marketing.
    • Test marketing of multi-channel distribution.
    • Test marketing of media, PR, pricing, and product endorsement plans.
    • Objective to recover production start-up expenses and the first year of depreciation for initial three molds in year 1.

    And here’s what comes next:

    • Limiting loss to less that $200K for the second year
    • Reaching limited retail distribution by year three (2nd salesyear).
    • In year three, you will be able to achieve profitable operations

    1.1 Objectives

    Professional Athletic Equipment, Inc. set a modest goal to achieve its first year sales. When we reach these minimums, it will be close to the over-all breakeven point for year one. This will allow us to expand our business in year two.

    The sales targets by size are:

    • Units as small as 4500
    • Medium’#82112250 units
    • Large&#82112250 units

    These targets will lead to year one sales volume at $242,550. This will be a confirmation of a successful test.

    To keep projected margins at these low sales levels, costs are controlled. If sales exceed these goals additional production and stepped-up marketing activity can be implemented quickly, although additional capital will be required on short notice in order to fully implement growth. Some sales may not be made in year 2, but that is to be expected.

    1.2 Mission

    Professional Athletic Equipment, Inc. is a manufacturing and marketing company dedicated to protecting young athletes from tragic injury and death. We plan to create quality, tested products as well as sufficient profit to provide fair returns for our investors. Our first product, the ‘#8220’ Body Armor, will go direct to consumers who are parents of youth players. The ‘#8220’Body Armor is designed to prevent injury and improve athletic performance by enhancing confidence among young athletes. The ‘#8220’Body Armor is designed to promote the enjoyment of sport by young people. We plan to expand the business and establish ourselves as an innovator and product leader in our niche. After our marketing platform is established, we will continue to finance internal and external growth. Once that happens, we will develop and acquire additional products. We will be a business that adheres to Christian values.

    1.3 Keys To Success

    Professional Athletic Equipment, Inc. has the following keys to its success:

    • Product Quality. New molds must be made and new production commenced. It is necessary to locate suppliers for all components and place initial orders. With rework and waste kept to a minimum, delivery and assembly must be done on time.
    • Marketing. Professional Athletic Equipment, Inc. can only be successful if the product is quality. The “Body Armor”, a new product, is not available yet. Therefore, consumers need to be aware of its availability and purpose. It is critical that media costs are controlled to increase sales.
    • Management.

    Although there’s a temptation for a company to grow exponentially, Professional Athletic Equipment, Inc. should focus first on product sales within certain price points, margin requirements, distribution routes, and consumer acceptance. After these answers have been found, controlled expansion (which involves increased production and investments in inventory) can then be achieved with confidence.

    Medical Software Business Plan


    Medical Software Business Plan


    Overview

    AgaMatrix (a Boston-based venture in development) offers digital signal processing (DSP), technology that significantly improves the performance and functionality of biosensors. AgaMatrix’s core DSP algorithms solve a number of immediate problems in the medical devices market by significantly boosting the performance of biosensors without costly specialized hardware and additional chemicals. AgaMatrix initially will sell medical device manufacturers, specifically home glucose monitors and point-of-care blood analyzers. AgaMatrix plans to have positive cash flow for the third consecutive year. Future targets in healthcare include the large immunoassay sector and implantable sensor sectors.

    Problem – Glucose Monitors Are Burdensome, Painful To Use

    Patients with diabetes fail to use their home glucose monitors as directed because it is too difficult or painful. To insert the glucose biosensor, a patient must do this four to seven days per day. The average testing compliance rate for diabetes is less than 1.5 per day. This causes complications like blindness or stroke and can accelerate the progression of these conditions, including heart and kidney disease. Diabetes is the most common cause of blindness for people aged 20 to 74. Therefore, better glucose monitoring compliance could be the biggest step towards prevention. Device manufacturers have identified that non-compliance stems from the physical pain experienced when using their devices. Therefore, they are looking for ways to decrease the size of the samples required by their devices. AgaMatrix technology will enable less invasive drawing mechanisms to meet the overwhelming demand for less painful alternatives.

    Problems in the hospital blood analyzer market are more related to the lack of the comprehensiveness and accuracy of the devices, which results in reduced adoption levels. AgaMatrix&#8217’s value proposition is very clear to this market: devices that have higher accuracy and more sensitive will be more likely to be adopted.

    A Software Solutions for a Hardware Issue

    The biosensor device industry has tried to overcome issues such as accuracy, robustness, and sensitivity by improving the hardware (or chemical) aspects of its devices. For example, their chemical and biological design. By contrast, AgaMatrix is pioneering a software approach based on digital signal processing (DSP) algorithms that has a number of distinct practical advantages, including lower cost, easier/faster upgrade capability, and complementarity with respect to a wide variety of chemistry/hardware-based biosensor technologies.

    AgaMatrix’#8217;s solution consists of a series of software modules. This allows for new functionality, and dramatically improves performance of biosensors. Performance improvements include the possibility to use increases in signal to noise ratio to reduce blood sampling requirements. AgaMatrix can be used to increase the accuracy and sensitivity for hospital point of care analyzers. This eliminates the major obstacle to widespread adoption of portable blood analyzers instead of traditional laboratory equipment.

    Software DSP solutions were crucial to the success and growth of other industries, where physical limitations might have hindered their growth. CD players, for example, relied on error-correction algorithms and oversampling in the 1980s to compensate low quality hardware filters. AgaMatrix algorithms provide similar solutions in biosensor space.

    Business Model: Software Licensing from Device Makers and Royalty Fees

    AgaMatrix initially will be a technology licensing firm, generating royalty revenue streams based upon device makers’ consumables sales (i.e. disposable test strips or cartridges used in devices). Revenues will be generated from the sales of the technology to blood glucose device makers at home, hospital point–of-care and implantable developers.

    Therasense: An Illustration of How Disruptive the Glucose Industry Is

    Only a few years back, the blood glucose market was dominated primarily by four players (numbers denote annual revenues from test strips).

    27B), J & J (1.09B), Bayer (650M), Abbot (450M) These companies have existed since the 1980’s. They have grown their market capitalization to over $800million in less than 2 years after their product rollout. The bottom line is that this market is very open for new technology entrants, especially if they can lower pain for the user.

    Competitive advantageThere is no direct competitor to our proprietary and highly innovative approach, which has been refined over the past seven year by our top-notch scientific team. AgaMatrix technology is complementary to indirect competition from major medical devices manufacturers’ in-house laboratories. The sustainable competitive advantages that AgaMatrix commands include:

    • Superior software paradigm, complementing chemical (hardware), advancements in biosensors.
    • The seven-year period of biosensor research was a time of great expertise.
    • Monopolization of the scientific group responsible for the original paradigm-innovation.
    • Development lead time of at least two years over potential competition.
    • Intellectual property strategy involving two core utility patents (filed) and three defensive utility patents.

    Customer Transaction

    Two manufacturers of hospital point-of care devices and a blood glucose monitor manufacturer have been approached as potential customers. There are 20 more potential target companies we haven’t reached yet. Below is a list of companies that we have made contact with.

    • Strong interest to partner from two blood glucose monitor companies (discussions with Presidents); details are confidential at this point, but we believe we will be able to close a deal by June 2002.
    • Strong interest from a top blood glucose monitor manufacturer (J & J – discussions avec Director-level employees) and the leading hospital point of care device maker (iSTAT – discussions mit Vice President und Director-level employees).

    The Team

    The current team is made up of:

    • The three top scientists in the field of digital signal processing have over 40 years combined experience in biosensor research and DSP.
    • Entrepreneurs that have started, built and operated a company offering enterprise-level software.
    • An expanding group of veteran advisors consisting of doctors with healthcare business experience.
    • Three additional technical staff members have committed to the company’s success after seed financing. They are engineers from MIT or Tufts with more than 25 years of combined commercial engineering experience.

    Financing

    Since its inception AgaMatrix is self-funded every year by its founders. Recently, the company raised $500K from a variety of angel investors in healthcare as well as IncTANK, an earlier stage venture capital fund. A Series A round of approximately 1 million is expected to take place in 4 to 5 months.

    These rounds of funding aim to finish version 1.0 products and acquire at minimum one paying customer in a period not exceeding 13 months. Given the current state of customer traction and product development, we believe these milestones are reasonable. The company hopes to raise around $4 million through an institutional or other private round before the end of the first year to generate cash flow. Current valuation drivers include:

    • A scientific team of world-class scientists, including Dr. SridharIyengar (CTO), Justin Gooding and Dr. Ian Harding. The engineering team is supported by an aggressive business team, with management and start-up experience.
    • Technology that is useful in a variety other vertical markets. It is protected by an IP strategy.
    • External validation from existing relationships with potential customers and advancement to final rounds in a number of national business plan competitions.

    1.1 Mission

    AgaMatrix designs solutions that power next-generation chemical and biological sensor systems. AgaMatrix’s ability to significantly improve the accuracy, sensitivity and robustness of a variety of sensors is what makes it stand out in this market. This allows for more efficient medical diagnostic devices.

    AgaMatrix’s technology enables the development of devices that will be essentially painless to patients and that will meet the demand for better accuracy in medical diagnostics. It is committed to developing software solutions for a critical problem in hardware that affects millions upon millions of hospital patients and diabetics worldwide.

    1.2 Objectives

    • Design technology solutions that will increase adoption and compliance rates of diagnostic medical equipment by improving functionality and performance of biosensors.
    • In the third year, achieve positive cashflow.
    • To reach $50 million annual revenues in four years
    • Expand into industries that heavily rely in biosensors like industrial processing and military sectors.

    Medical Equipment Business Plan


    Medical Equipment Business Plan


    MedNexis, Inc. (the company) is a medical device development company that has designed and patented medical devices which it plans to produce and market. An electromagnetic muscle stimulator/field generator has been developed with the collaboration of leading medical professionals and biomedical experts. Initiated patent number 1

    Allopathic Medicine

    One market addresses the unmet need for atrophy prevention/treatment in conditions that result in patient immobilization lasting more than two weeks. Two weeks of immobilization results in a muscle losing over 30%, which means that it will take longer to recover fully. MedStim, a novel and innovative design, was developed to meet this need. As more research about the benefits and uses of pulsed magnetic fields is conducted, the number of possible indications for this device will increase. For example, pulsed field magnetism has recently been shown in controlled studies to be an effective treatment in accelerating the healing of skeletal fractures.

    The market for allopathic medicine magnetic stimulation devices is already there, though it’s still in its infancy and could explode once the technology proves economical. The potential market for magnetic stimulation devices in allopathic medicine has been estimated at 4.2 million Americans. MedStim was the name of the innovative, new device developed to target this particular market.

    Alternative Medicine

    Another market addresses a gap in the alternative market for a device providing a stronger and longer-lasting therapeutic magnetic field. Dynamic magnetic fields therapy (the treatment and manipulation of soft tissue using variable magnetic pulses) has been shown to have beneficial effects on the immune system, circulation, wound healing, and other aspects of alternative healthcare. The strength of the magnetic fields generated is thought to determine these effects. TheraMag is a new, innovative system that was created to address the need for stronger therapeutic magnetic fields in alternative medicine. The market exists and it is estimated that there will be approximately 40 million US customers by the time we start.


    Technology

    Patent applications covering the company’s initial market entries were filed by a biomedical device patent specialist patent agent. MedNexis’#8217TM technology uses the principle that a magnet in a coil generates a magnetic fields which, in turn creates a current through any conductive materials within this field. This model is used for diagnostic studies. Single nerves can be stimulated with magnetism to diagnose. MedNexis created an electromagnetic device to painlessly stimulate muscles to contract by using this model. Applications of this technology are numerous, with the following devices being those initially marketed:

    MedNexis’#8217’s patented device will be able to stimulate muscle effectively. This device will need higher electrical currents, more functionality and a wider range settings. This device will not be sold in the mainstream of allopathic medicine.

    TheraMag- MedNexis’ patented device will bathe tissue in a magnetic field without causing contraction of the muscle. This device will be used in other applications.


    Strategy

    MedNexis will target both allopathic and alternative medicines. The devices will be named separately in order to distinguish them from possible negative connotations associated allopathic medicine.

    MedStim will only be available through major distributors. It will not be accessible to the general public via other channels. Partnership with these companies will be crucial for gaining market acceptance. MedNexis’#8217 will concentrate its initial efforts in this area on producing controlled, randomized study data.

    TheraMag will be distributed in alternative medicine centers that are less centralized and direct sales of TheraMag will also be possible. This market will not require any scientific proof. Entry to the market is possible as soon as the FDA issues an Investigational Device Exemption.

    Regulation Issues

    Through obtaining an Investigational Device Exemption and clearly labeling the product “

    FDA regulations will be met and market entry will be expedited. These products will be accepted on the basis of successful research results. It will significantly increase demand and facilitate expansion to foreign countries.


    Major Milestones

    Research and Development in the Animal Stages is underway, early Year 1.

    • Expand patent coverage to Australia and Canada in the middle of Year One
    • Human clinical trials underway, middle Year Two.
    • Publication of research studies at the end of Year Two
    • TheraMag on sale at the end of Year One
    • MagnaStim available for sale, end-of-year two, labeled ‘For Investigational Only’.
    • Year Four is the year of profitability


    Competitive advantage

    The MagnaStim & TheraMag devices work well and are user-friendly. But, other devices that are currently on the markets are less effective, or more difficult to use, for the recommended therapeutic treatment. MedNexis is utilizing its patent-pending designs to meet the market’s need for a better, easier-to use magnetic stimulator/field generator.


    Financial

    According to financial projections, the company will be profitable by year 3 if it receives $750,000 in funding. The company projects $23.5M in sales and a huge net profit by year 3. This projection is based upon penetration of less then 3% in every market segment.

    Medical Scanning Lab Business Plan


    Medical Scanning Lab Business Plan


    Scan Lab Medical Imaging (a start-up) offers a variety medical image scan tests for New Bedford and the surrounding communities.

    The Market

    Scan Lab is targeting insurance carriers. To set up contracts for medical scanning service providers, insurance companies will use a process called a submittal. These contacts are crucial in today’s medical environment, as 99% of scans are billed to insurance. The gatekeepers are insurance companies. Scan Lab realizes the importance in getting insurance carrier approval and will work hard on all plans.

    Once Scan Lab is approved by insurance companies, it will depend on physicians referring their patients to Scan Lab. Doctors refer patients based on many factors, including their geographic location, convenience, insurance accepted, scan type, and who they know. It is important to create strong marketing campaigns that alert doctors to Scan Lab’s services.

    Services

    Scan Lab offers a range of radiology based medical scanning tests. Scan Lab has the latest equipment and the expert medical training to interpret and provide valuable consultations to the physicians who make the patient referrals to Scan Lab.

    Management

    Dr. Carolyn Jones leads Scan Lab. Dr. Jones received her medical degree with a specialization in radiology from the University of California San Diego, a nationally recognized medical school for radiology. John Hopkins is also nationally recognized for its radiology program. Dr. Jones completed her residency there. Dr. Jones was a radiology physician for 13+ years at a large Boston hospital.

    1.1 Mission

    Scan Lab’s goal is to be the leader in New Bedford medical scanning technology. This will be possible through friendly service and flexible acceptance of insurance plans.

    1.2 Objectives

    • To capture 40% local physicians’#8217’ business in two years.
    • To achieve profitability in two years.
    • To double sales by the end of year three.

    1.3 Keys to Success

    • Only purchase equipment for medical use that is in demand.
    • Fast, friendly and accurate service.
    • For medical imaging equipment that requires high-end capital, strict financial controls are necessary to manage them.


    Surgical Medical Equipment Business Plan


    Surgical Medical Equipment Business Plan


    Bioring SA makes niche-specific rings to repair cardiac valves. It has its headquarters in Lonay CH and a small manufacturing/assembly plant in Lonay Switzerland. Its products may be sold by one distributor or many.

    • This business plan is part our regular business planning process. This plan is reviewed every quarter. It is then placed under change control.
    • We intend to create two new products in the next two years and to increase revenues.
    • The following are key success factors and important factors that will help you succeed in the coming year.
      • Product approval: CE mark.
      • Sales to dealers in volume.
      • Planning for cash flow and financial control

    Below is a chart that shows highlights of our financial performance for the next three-years. Profits and sales should grow.

    1.1 Objectives

    1. To provide Bioring SA with the market presence necessary to support sales and marketing goals and to attract distributors for new Bioring products.
    2. To develop two new Bioring products by the end of year four.
    3. To increase sales to reach $312,500 monthly sales by the end of year two, and $830,000 monthly by the end of month eight of year three.
    4. To manage expenditures in order to maximize dividends for shareholders.

    1.2 Mission

    Bioring SA focuses on open-heart surgery techniques. This business is based on a product owned by the company, which is a cardiac implant more precisely called “Kalangos Biodegradable Ring.”

    We will make enough profit to return fair returns to investors and fund continued growth and development of high-quality products. We maintain a fair, friendly, and creative workplace that values diversity, new ideas and hard work.

    Success Keys 1.3

    The keys to success in the business are:

    • Marketing: you can deal with local distributors or established international companies.
    • Product quality.
    • Approval of products in Europe or the USA
    • Management: products delivered on schedule, costs controlled, marketing budgets monitored. It’s easy to fixate on growth at all costs.